Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Seminars in Liver Disease
|
May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice
Fernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
Expert Review of Clinical Pharmacology
|
January 16, 2014
Idiosyncratic drug hepatotoxicity: a 2008 update
Raúl J Andrade, Susana López-Ortega, M Carmen López-Vega, et al.
Archives of Toxicology
|
August 28, 2020
Drug induced liver injury: an update
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, et al.
World Journal of Gastroenterology
|
January 19, 2007
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists
Raúl-J Andrade, Mercedes Robles, Alejandra Fernández-Castañer, et al.
Gastroenterology Report
|
May 2, 2022
Acute hepatitis with autoimmune features after COVID-19 vaccine: coincidence or vaccine-induced phenomenon?
José M Pinazo-Bandera, Alicia Hernández-Albújar, Ana Isabel García-Salguero, et al.
Expert Opinion on Drug Safety
|
August 19, 2016
Hepatotoxicity induced by coxibs: how concerned should we be?
Fernando Bessone, Nelia Hernandez, Marcelo Gabriel Roma, et al.
Alimentary Pharmacology & Therapeutics
|
December 22, 2022
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis
Hao Niu, Jiayi Ma, Inmaculada Medina-Caliz, et al.
Pharmacological Research
|
December 28, 2020
Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials
Hao Niu, Judith Sanabria-Cabrera, Ismael Alvarez-Alvarez, et al.
Plos One
|
April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Plos One
|
October 17, 2015
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Seminars in Liver Disease
|
May 4, 2019
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice
Fernando Bessone, Mercedes Robles-Diaz, Nelia Hernandez, et al.
Expert Review of Clinical Pharmacology
|
January 16, 2014
Idiosyncratic drug hepatotoxicity: a 2008 update
Raúl J Andrade, Susana López-Ortega, M Carmen López-Vega, et al.
Archives of Toxicology
|
August 28, 2020
Drug induced liver injury: an update
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, et al.
World Journal of Gastroenterology
|
January 19, 2007
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists
Raúl-J Andrade, Mercedes Robles, Alejandra Fernández-Castañer, et al.
Gastroenterology Report
|
May 2, 2022
Acute hepatitis with autoimmune features after COVID-19 vaccine: coincidence or vaccine-induced phenomenon?
José M Pinazo-Bandera, Alicia Hernández-Albújar, Ana Isabel García-Salguero, et al.
Expert Opinion on Drug Safety
|
August 19, 2016
Hepatotoxicity induced by coxibs: how concerned should we be?
Fernando Bessone, Nelia Hernandez, Marcelo Gabriel Roma, et al.
Alimentary Pharmacology & Therapeutics
|
December 22, 2022
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis
Hao Niu, Jiayi Ma, Inmaculada Medina-Caliz, et al.
Pharmacological Research
|
December 28, 2020
Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials
Hao Niu, Judith Sanabria-Cabrera, Ismael Alvarez-Alvarez, et al.
Plos One
|
April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Plos One
|
October 17, 2015
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort
Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.
Page
of 8